TD Asset Management’s CytomX Therapeutics CTMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-78,821
| Closed | -$609K | – | 1529 |
|
|
2021
Q1 | $609K | Buy |
+78,821
| New | +$609K | ﹤0.01% | 1368 |
|
|
2019
Q4 | – | Sell |
-35,182
| Closed | -$260K | – | 1403 |
|
|
2019
Q3 | $260K | Sell |
35,182
-11,400
| -24% | -$84.2K | ﹤0.01% | 1269 |
|
|
2019
Q2 | $523K | Hold |
46,582
| – | – | ﹤0.01% | 1177 |
|
|
2019
Q1 | $501K | Sell |
46,582
-13,900
| -23% | -$149K | ﹤0.01% | 1189 |
|
|
2018
Q4 | $913K | Sell |
60,482
-4,400
| -7% | -$66.4K | ﹤0.01% | 1078 |
|
|
2018
Q3 | $1.2M | Buy |
64,882
+17,682
| +37% | +$327K | ﹤0.01% | 1121 |
|
|
2018
Q2 | $1.08M | Buy |
47,200
+3,700
| +9% | +$84.6K | ﹤0.01% | 1112 |
|
|
2018
Q1 | $1.24M | Buy |
+43,500
| New | +$1.24M | ﹤0.01% | 1005 |
|